24.12.2023, 2504 Zeichen

Marinomed: Marinomed Biotech AG considers strategic options for its Carragelose business and has mandated an external advisor. A structured process was initiated, in which Marinomed and the advisor will start engaging with potential partners. This initiative meets an attractive market environment for those assets that comply with the new EU medical device regulation (MDR). In May 2024, an important interim period ends imposing challenging requirements for all medical devices. Products that don’t fulfil these requirements lose their certificate and must not be marketed. Carragelose products fulfil all necessary prerequisites for the MDR and are backed by extensive clinical data, comprising >1000 patients in 12 international clinical trials. Carragelose is a unique, patent-protected, broadly active virus-blocking compound and is currently used in a marketed product portfolio for the prophylaxis and treatment of viral respiratory infections. Recent clinical data also support the extension of using Carragelose in Allergy and Eye Care, while the potential of further applications is not yet fully exploited. “MDR-ready products receive a lot of interest from OTC-focused companies. Carragelose products are MDR-ready, which underpins that the time for starting a structured process is right now. It may also become an option in our effort to support the financial stability and flexibility of Marinomed. At the same time, the negotiations for restructuring the debt with the EIB are on the right track. We are still driven by our goal to become profitable in 2024,” Pascal Schmidt, CFO of Marinomed, says. Marinomed Biotech: weekly performance: -4.00%

Austrian Post: The Supervisory Board of Austrian Post appointed Walter Oblin as Chairman of the Management Board and CEO of Austrian Post. The appointment takes effect on 1 October 2024. Walter Oblin has been with the company since 1 October 2009 and has been Chief Financial Officer of Austrian Post since 1 July 2012. On 1 January 2019, he was appointed Deputy Chief Executive Officer and, in addition to his role as Management Board Member responsible for Finance, also took on responsibility for the Mail Division. Walter Oblin will continue in his current role as Management Board Member responsible for Finance and Mail (CFO) until he takes over the position of the Chairman of the Management Board.
Österreichische Post: weekly performance: 2.66%

(From the 21st Austria weekly https://www.boerse-social.com/21staustria (18/12/2023)

Christian Drastil: Wiener Börse Plausch

Wiener Börse Party #809: Post-Xmas-Boom bei Aktien von Pierer Mobilty, AT&S, Porr, UBM und Palfinger; Infos zum Jahresendhandel

Bildnachweis

Aktien auf dem Radar:Pierer Mobility, Warimpex, RHI Magnesita, Immofinanz, Addiko Bank, CA Immo, Mayr-Melnhof, Verbund, ATX, ATX Prime, ATX TR, Wienerberger, Kostad, EVN, Lenzing, Österreichische Post, Strabag, Athos Immobilien, AT&S, Cleen Energy, Marinomed Biotech, RWT AG, SBO, UBM, Agrana, Amag, Flughafen Wien, OMV, Palfinger, Telekom Austria, Uniqa.

---